Skip to main content
. Author manuscript; available in PMC: 2013 Apr 2.
Published in final edited form as: J Pharmacogenomics Pharmacoproteomics. 2011 Apr 4;2(103):1000103. doi: 10.4172/2153-0645.1000103

Table 2.

Demographic, asthma control, and health utilization variables stratified by subjects who provided specimens versus subjects who did not provide specimens for genetic analyses.*

N = 644 Provided Specimen(n=138) Did Not Provide Specimen (n=506) p-value

Specimen Group <0.0001
 Buccal 30% (78) 70% (181)
 Blood 16% (60) 84% (325)

Age (years) 0.03
 4–<18 23% (113) 77% (368)
 18–38 15% (25) 85% (138)

Gender 0.46
 Male 23% (81) 78% (279)
 Female 20% (57) 80% (227)

No. dispensings of inhaled corticosteroids in 1 year 0.27
3 18% (30) 82% (139)
4 22% (35) 78% (126)
5 18% (18) 82% (84)
6 23% (15) 77% (49)
7+ 27% (40) 73% (108)

Emergency Department Visits 0.50
0 23% (32) 77% (107)
1 25% (36) 75% (109)
2 18% (21) 82% (98)
3+ 20% (49) 80% (192)

Hospitalizations 0.72
0 22% (137) 78% (498)
1 13% (1) 88% (7)
2 0% (0) 100% (1)

In 208 subjects who completed telephone interview
Race 0.37
 Caucasian 72% (100) 60% (42)
 Black 13% (18) 21% (15)
 Asian 7% (10) 7% (5)
 Other 7% (10) 11% (8)

Asthma Control
Good 29% (40) 36% (16) 0.35
Poor 71% (98) 64% (54)
*

Note: Row percentages are provided rather than column percentages.